Low Dose Naltrexone: Clinical Trials

13 trials of Low Dose Naltrexone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 not yet recruiting, 2 withdrawn, 1 enrolling by invitation. 5 Phase 2, 4 Phase 4, 3 Not applicable, 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Not yet recruiting 1, Unknown 1, Withdrawn 1
Phase 44Completed 1, Enrolling by invitation 1, Not yet recruiting 1, Recruiting 1
Not applicable3Completed 2, Withdrawn 1
Phase 13Completed 2, Unknown 1

Follow Low Dose Naltrexone: new trials by email Literature Review of Low Dose Naltrexone trials Research Report on Low Dose Naltrexone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Pilot Study on the Efficacy of Oral Low Dose Naltrexone for Vulvodynia
Low Dose Naltrexone - Vulvodynia
Phase 2Not yet recruitingUniversity of Florida202027-01-012026-10-09
Low Dose Naltrexone Use in Patients With POTS
Low Dose Naltrexone, Microcrystalline cellulose - Postural Orthostatic Tachycardia Syndrome
Phase 4Not yet recruitingUniversity of Calgary802026-07-012026-05-01
Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome
Low dose naltrexone, Placebo sugar capsules - Complex Regional Pain Syndrome, Chronic Pain
Phase 4Enrolling by invitationHospital for Special Surgery, New York402024-01-022026-06-18
Low Dose Naltrexone for Pain in Patients With HIV
Low Dose Naltrexone - Human Immunodeficiency Virus, Chronic Neuropathic Pain
Phase 4RecruitingEmory University602023-04-282026-04-09
Efficacy of Low Dose Naltrexone in Psoriasis
Naltrexone Pill - Psoriasis
Phase 1CompletedJinnah Postgraduate Medical Centre422019-01-012020-01-31
St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene
Low dose naltrexone, Nalmefene - HIV Infection, Alcohol Use
Phase 1 / Phase 2CompletedBoston Medical Center112018-07-032020-08-24
Low Dose Naltrexone for Treatment of Pain in Patients With Fibromyalgia - Effect Via a Central Mechanism?
Low dose naltrexone, Placebo - Fibromyalgia
Phase 4CompletedCopenhagen University Hospital, Rigshospitalet582016-06-012024-02-23
Low Dose Naltrexone (LDN) Immune Monitoring
Low Dose Naltrexone - Fibromyalgia
Not applicableCompletedUniversity of Alabama at Birmingham92014-03-012017-04-11
Low Dose Naltrexone in Symptomatic Inflammatory Bowel Disease
Low dose naltrexone, Placebo - Inflammatory Bowel Disease, Crohn's Disease
Phase 2WithdrawnSanta Barbara Cottage Hospital2013-03-012014-11-20
Low Dose Naltrexone for Glioma Patients
LDN, Placebo - Malignant Glioma
Phase 2CompletedKaty Peters1102011-05-012015-07-17
Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome
Low Dose Naltrexone - Fibromyalgia
Not applicableWithdrawnStanford University2010-08-012015-12-11
Effects of Low Dose Naltrexone in Fibromyalgia
Low Dose Naltrexone, Placebo - sugar pill - Fibromyalgia, Persian Gulf Syndrome
Not applicableCompletedStanford University532007-06-012015-10-21
Trial of Low-Dose Naltrexone for Children With Pervasive Developmental Disorder (PDD)
low dose naltrexone - Pervasive Developmental Disorder
Phase 1 / Phase 2UnknownHadassah Medical Organization502006-05-03

Conditions studied

Fibromyalgia (4)  ·  Pain (3)  ·  Acquired Immunodeficiency Syndrome (1)  ·  Agnosia (1)  ·  Alcohol Drinking (1)  ·  Autistic Disorder (1)  ·  Causalgia (1)  ·  Child Development Disorders, Pervasive (1)  ·  Chronic Pain (1)  ·  Colitis, Ulcerative (1)  ·  Complex Regional Pain Syndromes (1)  ·  Crohn Disease (1)  ·  Glioblastoma (1)  ·  Glioma (1)  ·  HIV Infections (1)

Sponsors

Stanford University (2)  ·  Boston Medical Center (1)  ·  Copenhagen University Hospital, Rigshospitalet (1)  ·  Emory University (1)  ·  Hadassah Medical Organization (1)  ·  Hospital for Special Surgery, New York (1)  ·  Jinnah Postgraduate Medical Centre (1)  ·  Katy Peters (1)  ·  Santa Barbara Cottage Hospital (1)  ·  University of Alabama at Birmingham (1)  ·  University of Calgary (1)  ·  University of Florida (1)

Countries

United States (7)  ·  Denmark (1)  ·  Israel (1)  ·  Pakistan (1)  ·  Russia (1)

Top investigators

Jarred Younger (2)  ·  Alexandra Sideris, PhD (1)  ·  Anne M McKenzie-Brown, MD (1)  ·  David S Wilensky, MD (1)  ·  Erick J Imbertson, M.D. (1)  ·  Jarred Younger, PhD (1)  ·  Jeffrey H. Samet, MD, MA, MPH (1)  ·  Katherine B Peters, MD, PhD (1)  ·  Kirsten M Bested, MD (1)  ·  Rabia Ghafoor, FCPS (1)  ·  Satish R Raj, MD MSCI (1)  ·  Sean Mackey (1)  ·  Semih Gungor, M.D. (1)

Results publications

PMID 23359310, PMID 17222320, PMID 19365548, PMID 21991594, PMID 23188075, PMID 24558033, PMID 30937241, PMID 33682527, PMID 35001215

NIH funding

2015 (1), UH2AA026193 (1)